Aug 15 (Reuters) - Cynapsus Therapeutics Inc CTH.TO :
* Cynapsus announces positive opinion from data and safety monitoring board on Phase 3 Parkinson's Disease clinical study allowing for at-home titration Source text for Eikon: ID:nGNXMZIQVa Further company coverage: CTH.TO